| | | | | | | |
| | Three Months Ended | |
| | March 26, 2022 | | March 27, 2021 | |
OPERATING ACTIVITIES: | | | | | | | |
Net income | | $ | 9,852,500 | | $ | 9,311,100 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | |
Depreciation and amortization | | | 102,500 | | | 113,800 | |
Provision for credit losses | | | (8,900) | | | (48,700) | |
Compensation expense related to stock options | | | 421,600 | | | 385,200 | |
Deferred income taxes | | | (113,200) | | | (439,900) | |
Deferred initial direct costs | | | — | | | (1,500) | |
Amortization of deferred initial direct costs | | | — | | | 10,500 | |
Operating lease right of use asset amortization | | | 60,300 | | | 54,200 | |
Tax benefits on exercised stock options | | | 95,300 | | | 47,100 | |
Change in operating assets and liabilities: | | | | | | | |
Receivables | | | (369,900) | | | (515,000) | |
Principal collections on lease receivables | | | 530,500 | | | 2,268,700 | |
Income tax receivable/payable | | | 2,946,500 | | | 3,333,300 | |
Inventories | | | (167,100) | | | (3,600) | |
Prepaid expenses | | | 23,500 | | | 155,300 | |
Other assets | | | (10,400) | | | (2,600) | |
Accounts payable | | | (203,000) | | | (370,300) | |
Accrued and other liabilities | | | 390,500 | | | (532,300) | |
Rents received in advance and security deposits | | | (159,700) | | | (95,400) | |
Deferred revenue | | | (43,100) | | | (84,900) | |
Net cash provided by operating activities | | | 13,347,900 | | | 13,585,000 | |
INVESTING ACTIVITIES: | | | | | | | |
Purchase of property and equipment | | | (21,500) | | | (34,300) | |
Purchase of equipment for lease contracts | | | — | | | (65,500) | |
Net cash used for investing activities | | | (21,500) | | | (99,800) | |
FINANCING ACTIVITIES: | | | | | | | |
Proceeds from borrowings on line of credit | | | 15,600,000 | | | — | |
Payments on line of credit | | | (2,000,000) | | | — | |
Payments on notes payable | | | (1,062,500) | | | (1,062,500) | |
Repurchases of common stock | | | (36,591,400) | | | (10,455,200) | |
Proceeds from exercises of stock options | | | 1,258,300 | | | 268,800 | |
Dividends paid | | | (1,625,300) | | | (935,400) | |
Net cash used for financing activities | | | (24,420,900) | | | (12,184,300) | |
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | | | (11,094,500) | | | 1,300,900 | |
Cash, cash equivalents and restricted cash, beginning of period | | | 11,437,000 | | | 6,684,000 | |
Cash, cash equivalents and restricted cash, end of period | | $ | 342,500 | | $ | 7,984,900 | |
SUPPLEMENTAL DISCLOSURES: | | | | | | | |
Cash paid for interest | | $ | 490,500 | | $ | 309,200 | |
Cash paid for income taxes | | $ | 143,100 | | $ | 94,100 | |
| | | | | | | |
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Balance Sheets to the total of the same amounts shown above: |
| | Three Months Ended | |
| | March 26, 2022 | | March 27, 2021 | |
Cash and cash equivalents | | $ | 287,500 | | $ | 7,959,900 | |
Restricted cash | | | 55,000 | | | 25,000 | |
Total cash, cash equivalents and restricted cash | | $ | 342,500 | | $ | 7,984,900 | |